- Home
- YELP vs DNLI Comparison
YELP vs DNLI Comparison
Compare YELP & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YELP
- DNLI
- Stock Information
- Founded
- YELP 2004
- DNLI 2013
- Country
- YELP United States
- DNLI United States
- Employees
- YELP N/A
- DNLI N/A
- Industry
- YELP Other Consumer Services
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YELP Consumer Discretionary
- DNLI Health Care
- Exchange
- YELP Nasdaq
- DNLI Nasdaq
- Market Cap
- YELP 2.1B
- DNLI 2.1B
- IPO Year
- YELP 2012
- DNLI 2017
- Fundamental
- Price
- YELP $29.29
- DNLI $17.43
- Analyst Decision
- YELP Hold
- DNLI Strong Buy
- Analyst Count
- YELP 4
- DNLI 13
- Target Price
- YELP $32.00
- DNLI $32.64
- AVG Volume (30 Days)
- YELP 791.0K
- DNLI 1.5M
- Earning Date
- YELP 11-06-2025
- DNLI 11-06-2025
- Dividend Yield
- YELP N/A
- DNLI N/A
- EPS Growth
- YELP 37.30
- DNLI N/A
- EPS
- YELP 2.25
- DNLI N/A
- Revenue
- YELP $1,466,918,000.00
- DNLI N/A
- Revenue This Year
- YELP $6.16
- DNLI N/A
- Revenue Next Year
- YELP $3.80
- DNLI $94,232.03
- P/E Ratio
- YELP $13.00
- DNLI N/A
- Revenue Growth
- YELP 5.34
- DNLI N/A
- 52 Week Low
- YELP $27.91
- DNLI $10.57
- 52 Week High
- YELP $41.72
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- YELP 35.39
- DNLI 63.36
- Support Level
- YELP $27.91
- DNLI $13.75
- Resistance Level
- YELP $34.49
- DNLI $17.02
- Average True Range (ATR)
- YELP 1.13
- DNLI 0.93
- MACD
- YELP -0.43
- DNLI -0.02
- Stochastic Oscillator
- YELP 22.07
- DNLI 100.00
About YELP Yelp Inc.
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.